Delivery Order SPE2DB22D1202-SPE2DB24FVGS9

Award Date 7/12/24
Potential Completion Date 7/15/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,030.51, is for the delivery of Telmisartan-Amlodipine 40-5 mg 30s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 29, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $2,162.81, is a Firm Fixed Price Delivery Order for the supply of TELMISARTAN 40 MG TABLET 30S, a prescription cardiovascular medication. The contract has an ultimate completion date of November 22, 2023. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.42, is a delivery order for the supply of 4567615426 TELMISARTAN 40 MG TABLET 30S. The contract is a Firm Fixed Price arrangement with an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $1,530.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-Amlodipine 40-10 30S, a medication, with a completion date of June 10, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,992.64 firm fixed-price delivery order is for the supply of Telmisartan-Amlodipine 80-10 30S, a cardiovascular medication, with a period of performance through February 7, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,949.94, is a Delivery Order for Telmisartan-Amlodipine 40-10 30s tablets, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract, valued at up to $3,213.78, is for the delivery of 4564788163 - TELMISARTAN-AMLODIPINE 80-5 MG 30S, a pharmaceutical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type. It has an Ultimate Completion Date of June 4, 2024. This contract is...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.42, is for the delivery of TELMISARTAN-AMLODIPINE 80-5 MG 30S, a cardiovascular medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,303.60, is a delivery order for TELMISARTAN-HCTZ 40-12.5 MG TB UD 30S, a cardiovascular medication. The contract has a period of performance through November 12, 2024 and is a firm fixed-price contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,936.38 for the supply of Telmisartan-Amlodipine 40-5 mg medication. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 21, 2025. The contract type is Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVGS9
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,422.22, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The specific contract award is for 4565133476 ! TELMISARTAN-AMLODIPINE 40-10 30S, a pharmaceutical product, with a period of performance through July 15, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. As a major vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen's expertise in distributing a wide array of medical commodities, including specialty medications, generic drugs, and medical devices, makes it well-suited to fulfill this contract requirement.

Generated 5/17/25, 9:47 AM